Zobrazeno 1 - 10
of 197
pro vyhledávání: '"Frascerra, S."'
Publikováno v:
In Diabetes and Metabolism September 2016 42(4):242-248
Autor:
Antonelli, A., Ferri, C., Fallahi, P., Ferrari, S.M., Frascerra, S., Franzoni, F., Galetta, F., Zignego, A.L., Ferrannini, E.
Publikováno v:
In Digestive and Liver Disease 2009 41(1):42-48
Autor:
Bizzotto, R, Rayner, Ck, Watson, Le, Phillips, Lk, Lange, K, Bound, Mj, Grivell, J, Wu, T, Jones, Kl, Horowitz, M, Ferrannini, E, Trico, D, Frascerra, S, Natali, A, Mari, A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3728::5ef2d4b0a14e9f8e6859a18bc39818c3
http://hdl.handle.net/11568/1054758
http://hdl.handle.net/11568/1054758
Autor:
Rayner, C. K., Watson, L. E., Phillips, L. K., Bound, M. J., Grivell, J., Wu, T., Jones, K. L., Horowitz, M., Ferrannini, E., Trico, D., Frascerra, S., Mari, A., Natali, A.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b610dc471f0b8e2cf70adc9a6a9c291f
http://hdl.handle.net/11382/530435
http://hdl.handle.net/11382/530435
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Trico, D., Tulipani, A., Baldi, S., Trifiro, S., Frascerra, S., Mari, A., Ferrannini, E., Natali, A.
Publikováno v:
Diabetologia (Berl.) 56 (2013): S101.
info:cnr-pdr/source/autori:Trico, D.;Tulipani, A.;Baldi, S.;Trifiro, S.;Frascerra, S.;Mari, A.;Ferrannini, E.;Natali, A./titolo:Effect of a small protein and l ipid preload on oral glucose tolerance in subjects with normal and impaired glucose tolerance/doi:/rivista:Diabetologia (Berl.)/anno:2013/pagina_da:S101/pagina_a:/intervallo_pagine:S101/volume:56
info:cnr-pdr/source/autori:Trico, D.;Tulipani, A.;Baldi, S.;Trifiro, S.;Frascerra, S.;Mari, A.;Ferrannini, E.;Natali, A./titolo:Effect of a small protein and l ipid preload on oral glucose tolerance in subjects with normal and impaired glucose tolerance/doi:/rivista:Diabetologia (Berl.)/anno:2013/pagina_da:S101/pagina_a:/intervallo_pagine:S101/volume:56
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=cnr_________::6b433a4a54dec6a623ef5ffd30c34201
http://www.cnr.it/prodotto/i/277083
http://www.cnr.it/prodotto/i/277083
Autor:
Ferrannini, E., Muscelli, E., Frascerra, S., Baldi, S., Mari, A., Heise, T., Broedl, U.C., Woerle, H.-J.
Publikováno v:
Diabetologia (Berl.) 56 (2013): S392.
info:cnr-pdr/source/autori:Ferrannini, E.;Muscelli, E.;Frascerra, S.;Baldi, S.;Mari, A.;Heise, T.;Broedl, U.C.;Woerle, H.-J./titolo:Metabolic response to sodium-glucose transporter 2 (SGLT2) inhibition with empagliflozin in patients with type 2 diabetes/doi:/rivista:Diabetologia (Berl.)/anno:2013/pagina_da:S392/pagina_a:/intervallo_pagine:S392/volume:56
info:cnr-pdr/source/autori:Ferrannini, E.;Muscelli, E.;Frascerra, S.;Baldi, S.;Mari, A.;Heise, T.;Broedl, U.C.;Woerle, H.-J./titolo:Metabolic response to sodium-glucose transporter 2 (SGLT2) inhibition with empagliflozin in patients with type 2 diabetes/doi:/rivista:Diabetologia (Berl.)/anno:2013/pagina_da:S392/pagina_a:/intervallo_pagine:S392/volume:56
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=cnr_________::830388f640fcaba79670416214452408
http://www.cnr.it/prodotto/i/277172
http://www.cnr.it/prodotto/i/277172
Autor:
Antonelli, A, Fallahi, P, Ferrari, Silvia Martina, Corrado, A, Sebastiani, Marco, Manfredi, Andreina Teresa, Frascerra, S, Miccoli, M, Zignego, Al, Ferrannini, E, Ferri, Clodoveo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3674::4a7551e7ecfd9672e8a3acb1336fb7b6
https://hdl.handle.net/11380/853308
https://hdl.handle.net/11380/853308
Autor:
Antonelli, A., Ferri, Clodoveo, Fallahi, P., Ferrari, Silvia Martina, Giuggioli, D., Colaci, Michele, Manfredi, Andreina Teresa, Frascerra, S., Franzoni, F., Galetta, F., Ferrannini, E.
Publikováno v:
Rheumatology (Oxford, England). 47(1)
To measure serum levels of CXCL10 and CCL2 chemokines in patients with SSc, and relate the findings to clinical phenotype and disease progression.Serum CXCL10 and CCL2 were assayed in 72 consecutive newly diagnosed SSc patients and in 72 sex- and age
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::788758139e7978549c060a3313078388
https://pubmed.ncbi.nlm.nih.gov/18077490
https://pubmed.ncbi.nlm.nih.gov/18077490